Direkt zum Inhalt | Direkt zur Navigation

Eingang zum Volltext


Bitte beziehen Sie sich beim Zitieren dieses Dokumentes immer auf folgende
URN: urn:nbn:de:bsz:25-opus-8154
URL: http://www.freidok.uni-freiburg.de/volltexte/815/

Bossaller, Lukas Friedrich Magnus

Investigations on the role of SLP-65 and other B cell signaling proteins in human leukemia

Untersuchungen zur Rolle des Adaptorproteins SLP-65 und anderer B-Zell Signaltransduktionsproteine in menschlicher Leukämie

Dokument1.pdf (11.623 KB) (md5sum: 6b3a1793d372c215298d9c7da24f7aff)

Kurzfassung in Deutsch

SLP-65 is an adaptor protein preferentially expressed in B cells with a central role in BCR and pre-BCR mediated signal transduction. By providing multiple binding sites for other cellular effector molecules it assembles various proteins into one signaling complex. Therefore SLP-65 is involved in the control of different signaling pathways important for B cell development, survival and activation. SLP-65 KO mice demonstrated the critical role of SLP-65 in B cell development. Based on the fact that 5-10 of the SLP-65 KO mice develop pre-B cell leukemia most similar to childhood precursor B cell acute lymphoblastic leukemia, SLP-65 was analyzed in human tumor samples. SLP-65 expression was investigated by RT-PCR, immunoblotting and flow cytometry in 38 samples of precursor B acute lymphoblastic leukemia. In half of the cases SLP-65 protein was reduced or absent. Interestingly, aberrant SLP-65 mRNA splicing was detected in the tumor samples. Alternative exons containing pre-mature stop codons were included in the aberrantly spliced SLP-65 mRNA. These exons were shown to contain pre-mature stop codons leading to nonsense mediated decay of the aberrantly spliced SLP-65 mRNA. In addition, a genetic polymorphism involved in mediating exon recognition was identified. Three of ten patients were deficient for the transcription factor pax-5 involved in regulating SLP-65 expression and one of those patients had aberrant pax-5 mRNA’s lacking the sequences for the transactivation domain. Thus, loss of pax-5 expression could be another possibility to explain the SLP-65 deficiency in addition to aberrant splicing. Our data indicate that a block in pre-B cell differentiation, due to a somatic deficiency in key signaling elements combined with proliferation capacity and active RAG 1/2 enzymes may be the primary cause of pre-B ALL.

SWD-Schlagwörter: Akute lymphatische Leukämie , B-Lymphozyt , Tumorsuppressor-Gen , Zelldifferenzierung , Proteinkinasen
Freie Schlagwörter (deutsch): SLP-65 , BLNK , Adaptorprotein , BSAP , pax-5
Freie Schlagwörter (englisch): acute lymphoblastic leukemia , B lymphocyte , adaptorprotein , SLP-65 , tumorsuppressor
Institut 1: Institut für Biologie 3
Institut 2: Univ.-Kinderklinik
Fakultät: Medizinische Fakultät / Universitätsklinikum (bis Sept. 2002)
DDC-Sachgruppe: Medizin und Gesundheit
Dokumentart: Dissertation
Erstgutachter: Niemeyer, Charlotte M. (Prof. Dr. med.)
Quelle: Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia. Nature. 2003 May 22;423(6938):452-6.
Sprache: Englisch
Tag der mündlichen Prüfung: 18.07.2003
Erstellungsjahr: 2003
Publikationsdatum: 18.09.2003